Back
Sonoma Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
SNOA
Sonoma Pharmaceuticals, Inc.
Last Price:
$2.89
Seasonality Move:
-4.41%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNOA is experiencing slight buying pressure.
Sonoma Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.82 | Buy |
| 20-day SMA: | 3.07 | Sell |
| 50-day SMA: | 3.36 | Sell |
| 200-day SMA: | 3.59 | Sell |
| 8-day EMA: | 2.88 | Buy |
| 20-day EMA: | 3.03 | Sell |
| 50-day EMA: | 3.26 | Sell |
| 200-day EMA: | 3.54 | Sell |
Sonoma Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 39.78 | Sell |
| Chaikin Money Flow: | 3817 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.88 - 3.36) | Sell |
| Bollinger Bands (100): | (3.18 - 3.9) | Sell |
Sonoma Pharmaceuticals, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sonoma Pharmaceuticals, Inc. Stock
Is Sonoma Pharmaceuticals, Inc. Stock a Buy?
-
Sonoma Pharmaceuticals, Inc. share price is 2.94 while SNOA 8-day simple moving average is 2.82, which is a Buy signal.
-
The stock price of SNOA is 2.94 while Sonoma Pharmaceuticals, Inc. 20-day SMA is 3.07, which makes it a Sell.
-
Sonoma Pharmaceuticals, Inc. 50-day simple moving average is 3.36 while SNOA share price is 2.94, making it a Sell technically.
-
SNOA stock price is 2.94 and Sonoma Pharmaceuticals, Inc. 200-day simple moving average is 3.59, creating a Sell signal.
SNOA Technical Analysis vs Fundamental Analysis
Sell
20
Sonoma Pharmaceuticals, Inc. (SNOA)
is a Sell
Is Sonoma Pharmaceuticals, Inc. a Buy or a Sell?
-
Sonoma Pharmaceuticals, Inc. stock is rated a SellThe current Sonoma Pharmaceuticals, Inc. [SNOA] share price is $2.94. The Score for SNOA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Sonoma Pharmaceuticals, Inc. Stock Info
Market Cap:
5.1M
Price in USD:
2.94
Share Volume:
7.9K
Sonoma Pharmaceuticals, Inc. 52-Week Range
52-Week High:
6.92
52-Week Low:
1.75
Sell
20
Sonoma Pharmaceuticals, Inc. (SNOA)
is a Sell
Sonoma Pharmaceuticals, Inc. Share Price Forecast
-
What is the Sonoma Pharmaceuticals, Inc. stock price today?The Sonoma Pharmaceuticals, Inc. stock price is 2.94 USD today.
-
Will SNOA stock go up or go down?Sonoma Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Sonoma Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sonoma Pharmaceuticals, Inc. is overvalued.
Is Sonoma Pharmaceuticals, Inc. Stock a Buy?
-
Sonoma Pharmaceuticals, Inc. share price is 2.94 while SNOA 8-day exponential moving average is 2.88, which is a Buy signal.
-
The stock price of SNOA is 2.94 while Sonoma Pharmaceuticals, Inc. 20-day EMA is 3.03, which makes it a Sell.
-
Sonoma Pharmaceuticals, Inc. 50-day exponential moving average is 3.26 while SNOA share price is 2.94, making it a Sell technically.
-
SNOA stock price is 2.94 and Sonoma Pharmaceuticals, Inc. 200-day simple moving average is 3.54, creating a Sell signal.
Fundamental Analysis of Sonoma Pharmaceuticals, Inc.
Is Sonoma Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.05 per share.
Technical Analysis of Sonoma Pharmaceuticals, Inc.
Should I short Sonoma Pharmaceuticals, Inc. stock?
-
SNOA Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Sonoma Pharmaceuticals, Inc. is a Sell
-
Sonoma Pharmaceuticals, Inc. Relative Strength Index (RSI) is 39.78, which suggest Sonoma Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Sonoma Pharmaceuticals, Inc. is (2.88 - 3.36), which suggest Sonoma Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for Sonoma Pharmaceuticals, Inc. is (3.18 - 3.9), which suggest Sonoma Pharmaceuticals, Inc. is a Sell
* Sonoma Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.